Shenzhen Sangel Venture Capital Co., Ltd. is a Venture Capital investment firm established in 2010 in Shengzhen. Sangle Capital provides venture capital and business finance to support high-tech enterprises in China and western countries. The company seeks to invest innovative Emerging Market enterprises in sectors including: biomedicine, medical devices, healthcare and bio-tech.
Sangel Capital has set Sage-Angel incubator and Sangel funds and been managing more than 50 projects. In July, 2015, Sangle Venture Capital Co., Ltd. established its first international subsidiary—Sangel Venture Capital Corp. (US) in Chicago. This year, Sangel Venture Capital Co., Ltd. won "China Outstanding Venture Capital Institution in Next Generation Award".